AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1(+) CD8 T cells

Li, HY; Liu, ZD; Liu, LC; Zhang, HY; Han, CH; Girard, L; Park, H; Zhang, AL; Dong, CB; Ye, JF; Rayford, A; Peyton, M; Li, XG; Avila, K; Cao, XZ; Hu, SQ; Alam, MM; Akbay, EA; Solis, LM; Behrens, C; Hernandez-Ruiz, S; Lu, W; Wistuba, I; Heymach, JV; Chisamore, M; Micklem, D; Gabra, H; Gausdal, G; Lorens, JB; Li, B; Fu, YX; Minna, JD; Brekken, RA

Minna, JD; Brekken, RA (通讯作者),UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.;Minna, JD; Brekken, RA (通讯作者),UT Southwestern Med Ctr, Canc Biol Grad Program, Dallas, TX 75390 USA.;Liu, ZD; Fu, YX (通讯作者),UT Southwestern Med Ctr, Dept Pathol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.;Brekken, RA (通讯作者),UT Southwestern Med Ctr, Dept Surg, Dallas, TX 75390 USA.;Fu, YX (通讯作者),UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA.;Minna, JD;

CELL REPORTS MEDICINE, 2022; 3 (3):